在慢性心力衰竭中,热和促进尿液流动的血液激活方法的有效性
Xiaoyu Liu1, Hailiang Fang1, Yang Zhang1
1Department of Traditional Chinese Medicine, The Second Hospital of Dalian Medical University.
The Tohoku journal of experimental medicine
|July 24, 2024
概括
温暖的和促进尿液流动的血液激活方法 (WYLBAM) 在慢性心力衰竭患者中显著改善心脏功能和运动能力. 这种传统的干预措施显示出作为心力衰竭管理的有效补充治疗的希望.
科学领域:
- 综合医学是一个整体的医学.
- 心脏病学 心脏病学
- 传统中国医药 传统中国医药
背景情况:
- 慢性心力衰竭 (CHF) 是一个全球性的健康挑战,常规治疗方法的局限性.
- 温暖阳和促进尿液流动的血液激活方法 (WYLBAM) 是一种传统的干预措施,具有治疗心血管疾病的潜力.
- 缺乏对WYLBAM疗效和对心脏功能影响的系统评估.
研究的目的:
- 进行全面的元分析,评估WYLBAM在慢性心力衰竭 (CHF) 的临床疗效.
- 评估WYLBAM对心脏功能,身体能力和相关生物标志物的影响.
主要方法:
- 在多个数据库中按照PRISMA指南进行了系统的文献搜索.
- 26项随机对照试验将WYLBAM与标准护理进行比较,这些试验被纳入了分析.
- 提取并分析了临床疗效,左心室喷射率 (LVEF),心脏尺寸,6分钟步行测试和生物标志物 (BNP,NT-proBNP) 的数据.
主要成果:
- 怀尔巴姆治疗在临床疗效率,LVEF和左心室尺寸方面显著改善.
- 接受WYLBAM治疗的患者表现出增强的6分钟步行测试距离和BNP和NT-proBNP水平的显著降低.
- 由于实质性的异质性 (I2统计),采用了随机效应建模,没有发现显著的出版偏差.
结论:
- 在患有慢性心力衰竭的患者中,WYLBAM似乎是一种有益的辅助疗法,可以改善心脏功能和身体能力.
- 观察到的异质性强调了在实施WYLBAM时需要考虑个体患者因素的必要性.
- 建议进行进一步的大规模,精心设计的随机对照试验,以验证这些发现并阐明WYLBAM的作用机制.
相关概念视频
01:22Heart Failure Drugs: Diuretics
356
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
356
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
414
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414
01:16Antihypertensive Drugs: Action of Diuretics
647
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
647
01:22Heart Failure Drugs: β-Blockers
333
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
333
01:26Heart Failure Drugs: Inotropic Agents
559
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
559
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
495
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
495